协同靶向食管鳞癌PAFR/DGKα/FAK蛋白复合体及其肿瘤微环境的作用机制研究
结题报告
批准号:
81830086
项目类别:
重点项目
资助金额:
293.0 万元
负责人:
詹启敏
依托单位:
学科分类:
肿瘤学
结题年份:
2023
批准年份:
2018
项目状态:
已结题
项目参与者:
詹启敏
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
肿瘤细胞与其微环境互作介导肿瘤恶性进展。我们前期食管癌基因组研究发现多个调控细胞生长发育和肿瘤微环境的基因有遗传变异,包括PAFR、DGKα及FAK等重要促癌信号分子。我们发现:PAFR及DGKα在食管鳞癌(ESCC)中异常高表达,且与ESCC细胞中FAK结合并激活FAK;PAFR与DGKα可直接相互作用;DGKα促进多种巨噬细胞诱导细胞因子的释放。由于FAK是肿瘤细胞中调控M2型巨噬细胞(微环境重要组分)浸润关键的分子之一,因此,我们提出如下假设:PAFR、DGKα及FAK组成复合体激活FAK,募集M2型巨噬细胞,调控微环境,促进ESCC恶性进展;协同靶向PAFR/DGKα/FAK复合体和肿瘤微环境能够有效杀死食管癌肿瘤细胞。因此,本研究将首先揭示PAFR/DGKα/FAK复合体调控ESCC细胞与其微环境互作的机制,并为临床制定协同靶向癌基因与肿瘤微环境治疗ESCC的策略提供实验依据
英文摘要
The interaction of tumor cells and their microenvironment mediates the malignant progression of tumor. Our previous studies on esophageal cancer genome revealed that there are genetic variations in many genes regulating cell growth and development and tumor microenvironment, including PAFR, DGKα, FAK and other important tumor signal molecules. We found that: PAFR and DGKα are highly expressed in esophageal squamous cell carcinoma (ESCC), and bind to FAK and activate FAK in ESCC cells; PAFR can interact directly with DGKα; DGKα promotes the release of cytokines from multiple macrophages. FAK is one of the key molecules that regulate the infiltration of M2 macrophages (important components in microenvironment) in tumor cells. Therefore, we put forward hypothesis that PAFR, DGKα and FAK can form protein complex to activate FAK, recruit M2 macrophages, and resultantly promote the malignant progression of ESCC,synergistic targeting PAFR/DGKα/FAK complex and tumor microenvironment can effectively kill esophageal cancer cells. This study will hopefully reveal the mechanism of PAFR/DGKα/FAK complex regulating the interaction between ESCC cells and tumor microenvironment, and provide experiment evidence for formulating strategies for synergistically targeting ESCC cells and their microenvironment.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1002/1878-0261.12619
发表时间:2019-12
期刊:Molecular Oncology
影响因子:6.6
作者:Jiancheng Xu;Guangchao Wang;Wei Gong;Shichao Guo;Dan Li;Q. Zhan
通讯作者:Jiancheng Xu;Guangchao Wang;Wei Gong;Shichao Guo;Dan Li;Q. Zhan
DOI:10.21147/j.issn.1000-9604.2022.01.02
发表时间:2022-02-28
期刊:Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
影响因子:--
作者:Guo S;Wang G;Zhao Z;Li D;Song Y;Zhan Q
通讯作者:Zhan Q
DOI:10.1002/cac2.12127
发表时间:2021-03
期刊:Cancer communications (London, England)
影响因子:--
作者:Zhang H;Wang Y;Zhang W;Wu Q;Fan J;Zhan Q
通讯作者:Zhan Q
DOI:10.1007/s10620-019-05836-8
发表时间:2020-04-01
期刊:DIGESTIVE DISEASES AND SCIENCES
影响因子:3.1
作者:Li, Tongtong;Xu, Lele;Liu, Xuefeng
通讯作者:Liu, Xuefeng
Defect of SLC38A3 promotes epithelial-mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma.
SLC38A3的缺陷促进上皮间质转化并预测食管鳞状细胞癌的不良预后
DOI:10.21147/j.issn.1000-9604.2020.05.01
发表时间:2020-10-31
期刊:Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
影响因子:--
作者:Liu R;Hong R;Wang Y;Gong Y;Yeerken D;Yang D;Li J;Fan J;Chen J;Zhang W;Zhan Q
通讯作者:Zhan Q
肿瘤的分子变异与微环境
  • 批准号:
    --
  • 项目类别:
    基础科学中心项目
  • 资助金额:
    8000万元
  • 批准年份:
    2019
  • 负责人:
    詹启敏
  • 依托单位:
国内基金
海外基金